Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL
Chronic lymphocytic leukemia (CLL) cells cycle between lymph node (LN) and peripheral blood (PB) and display major shifts in Bcl-2 family members between those compartments. Specifically, Bcl-XL and Mcl-1, which are not targeted by the Bcl-2 inhibitor venetoclax, are increased in the LN. Because ibrutinib forces CLL cells out of the LN, we hypothesized that ibrutinib may thereby affect expression of Bcl-XL and Mcl-1 and sensitize CLL cells to venetoclax. We investigated expression of Bcl-2 family members in patients under ibrutinib or venetoclax treatment, combined with dissecting functional interactions of Bcl-2 family members, in an in vitro model of venetoclax resistance. In the PB, recent LN emigrants had higher Bcl-XL and Mcl-1 expression than did cells immigrating back to the LN. Under ibrutinib treatment, this distinction collapsed; significantly, the pretreatment profile reappeared in patients who relapsed on ibrutinib. However, in response to venetoclax, Bcl-2 members displayed an early increase, underlining the different modes of action of these 2 drugs. Profiling by BH3 mimetics was performed in CLL cells fully resistant to venetoclax due to CD40-mediated induction of Bcl-XL, Mcl-1, and Bfl-1. Several dual or triple combinations of BH3 mimetics were highly synergistic in restoring killing of CLL cells. Lastly, we demonstrated that proapoptotic Bim interacts with antiapoptotic Bcl-2 members in a sequential manner: Bcl-2 > Bcl-XL > Mcl-1 > Bfl-1. Combined, the data indicate that Bcl-XL is more important in venetoclax resistance than is Mcl-1 and provide biological rationale for potential synergy between ibrutinib and venetoclax.
2918-2926
Haselager, Marco Vincent
29ea9d3b-c1fe-45b9-8998-4b7b5e202145
Kielbassa, Karoline
88256acf-629a-4865-8a02-442d7dfd9983
Ter Burg, Johanna
7929d2e6-01e2-4ebb-9b96-a8a7c53266c2
Bax, Danique Johanna Cornelia
c203f894-7ea0-4ea4-838d-e376699655d7
Fernandes, Stacey Marie
6f52ea27-6217-402a-8a9d-f7b22742a069
Borst, Jannie
441e3d1f-8d6b-428e-b82e-ad856ffe9e1c
Tam, Constantine
29399e89-1999-4a9d-af9d-61f5abd86fba
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Chiodin, Giorgia
4b3e9525-b377-4d16-b69a-e05d2e7854fe
Brown, Jennifer R.
d45373cf-f656-4c6b-9397-3afffa4e1010
Dubois, Julie
e02d07c5-3bc5-445f-b906-23b3044652f3
Kater, Arnon P.
b0c9bb11-e6e5-4c8f-be47-a0b63aca2073
Eldering, Eric
3ceb48b0-8d2c-47b6-b8a0-0aff486e2e0f
17 December 2020
Haselager, Marco Vincent
29ea9d3b-c1fe-45b9-8998-4b7b5e202145
Kielbassa, Karoline
88256acf-629a-4865-8a02-442d7dfd9983
Ter Burg, Johanna
7929d2e6-01e2-4ebb-9b96-a8a7c53266c2
Bax, Danique Johanna Cornelia
c203f894-7ea0-4ea4-838d-e376699655d7
Fernandes, Stacey Marie
6f52ea27-6217-402a-8a9d-f7b22742a069
Borst, Jannie
441e3d1f-8d6b-428e-b82e-ad856ffe9e1c
Tam, Constantine
29399e89-1999-4a9d-af9d-61f5abd86fba
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Chiodin, Giorgia
4b3e9525-b377-4d16-b69a-e05d2e7854fe
Brown, Jennifer R.
d45373cf-f656-4c6b-9397-3afffa4e1010
Dubois, Julie
e02d07c5-3bc5-445f-b906-23b3044652f3
Kater, Arnon P.
b0c9bb11-e6e5-4c8f-be47-a0b63aca2073
Eldering, Eric
3ceb48b0-8d2c-47b6-b8a0-0aff486e2e0f
Haselager, Marco Vincent, Kielbassa, Karoline, Ter Burg, Johanna, Bax, Danique Johanna Cornelia, Fernandes, Stacey Marie, Borst, Jannie, Tam, Constantine, Forconi, Francesco, Chiodin, Giorgia, Brown, Jennifer R., Dubois, Julie, Kater, Arnon P. and Eldering, Eric
(2020)
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL.
Blood, 136 (25), .
(doi:10.1182/blood.2019004326).
Abstract
Chronic lymphocytic leukemia (CLL) cells cycle between lymph node (LN) and peripheral blood (PB) and display major shifts in Bcl-2 family members between those compartments. Specifically, Bcl-XL and Mcl-1, which are not targeted by the Bcl-2 inhibitor venetoclax, are increased in the LN. Because ibrutinib forces CLL cells out of the LN, we hypothesized that ibrutinib may thereby affect expression of Bcl-XL and Mcl-1 and sensitize CLL cells to venetoclax. We investigated expression of Bcl-2 family members in patients under ibrutinib or venetoclax treatment, combined with dissecting functional interactions of Bcl-2 family members, in an in vitro model of venetoclax resistance. In the PB, recent LN emigrants had higher Bcl-XL and Mcl-1 expression than did cells immigrating back to the LN. Under ibrutinib treatment, this distinction collapsed; significantly, the pretreatment profile reappeared in patients who relapsed on ibrutinib. However, in response to venetoclax, Bcl-2 members displayed an early increase, underlining the different modes of action of these 2 drugs. Profiling by BH3 mimetics was performed in CLL cells fully resistant to venetoclax due to CD40-mediated induction of Bcl-XL, Mcl-1, and Bfl-1. Several dual or triple combinations of BH3 mimetics were highly synergistic in restoring killing of CLL cells. Lastly, we demonstrated that proapoptotic Bim interacts with antiapoptotic Bcl-2 members in a sequential manner: Bcl-2 > Bcl-XL > Mcl-1 > Bfl-1. Combined, the data indicate that Bcl-XL is more important in venetoclax resistance than is Mcl-1 and provide biological rationale for potential synergy between ibrutinib and venetoclax.
Text
Haselager_Blood_R2
- Accepted Manuscript
More information
Accepted/In Press date: 17 June 2020
e-pub ahead of print date: 30 June 2020
Published date: 17 December 2020
Identifiers
Local EPrints ID: 444114
URI: http://eprints.soton.ac.uk/id/eprint/444114
ISSN: 0006-4971
PURE UUID: 28a850b6-c786-4ed0-a672-ad09f0e34048
Catalogue record
Date deposited: 25 Sep 2020 16:36
Last modified: 17 Mar 2024 05:46
Export record
Altmetrics
Contributors
Author:
Marco Vincent Haselager
Author:
Karoline Kielbassa
Author:
Johanna Ter Burg
Author:
Danique Johanna Cornelia Bax
Author:
Stacey Marie Fernandes
Author:
Jannie Borst
Author:
Constantine Tam
Author:
Giorgia Chiodin
Author:
Jennifer R. Brown
Author:
Julie Dubois
Author:
Arnon P. Kater
Author:
Eric Eldering
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics